Research and Treatment

Research & Treatment

Progress. For years, the bleeding disorders community has been waiting for meaningful progress for a greater understanding of hemophilia, for...
A six-year study by the US Centers for Disease Control and Prevention (CDC) of patients with inhibitors, antibodies to infused...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
When the US Food and Drug Administration (FDA) approved Tivicay® (dolutegravir), a new drug to treat HIV, in August 2013...
Update, November 2014: The St. Jude/UCL gene therapy trial now has data from all 10 participants, to be published in...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
This year’s mandatory federal budget cuts, known as “the sequester,” have been raising concerns about the future of biomedical research...
Research into treatments and cures for hemophilia takes place in laboratories all over the country. So it’s no wonder that...
Cryoprecipitate. Long-acting factor concentrates. Gene therapy trials. These are just a few of the incredible clinical advances from the past...
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.